150-cm Versus 200-cm Biliopancreatic Limb One-Anastomosis Gastric Bypass: Propensity Score-Matched Analysis.

Cohort Studies Gastric Bypass / methods Humans Malnutrition / epidemiology Obesity, Morbid / surgery Propensity Score Retrospective Studies Weight Loss
150-cm biliopancreatic limb length 200-cm biliopancreatic limb Mini gastric bypass Nutritional deficiencies One-anastomosis gastric bypass Weight loss

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
09 2022
Historique:
received: 02 04 2022
accepted: 04 07 2022
revised: 01 07 2022
pubmed: 9 7 2022
medline: 24 8 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

It has been suggested that shortening the length of the biliopancreatic limb (BPL) to 150 cm in one anastomosis gastric bypass (OAGB) would reduce nutritional complication rates without impairing weight loss outcomes. The aim of this study is to compare patients who underwent OAGB with a 200-cm BPL (OAGB-200) to patients with OAGB with a 150-cm BPL (OAGB-150) in terms of weight loss and late morbidity. This is a monocentric retrospective matched cohort study including patients with a body mass index between 35 and 50 kg/m In total, 784 patients who underwent OAGB were included (OAGB-150 n = 392 and OAGB-200 (n = 392). There was no significant difference in terms of early morbidity. Regarding late morbidity in patients with an OAGB-150, significantly lower rates for marginal ulcer (OR = 0.4, CI 95% [0.2; 0.8], p = 0.006), incisional hernia (OR = 0.5, CI 95% [0.3; 1], p = 0.041), and bowel obstruction (OR = 0.3, CI 95% [0.1; 0.9], p = 0.039) were reported. Likewise, regarding late nutritional deficiencies, post-OAGB-150, a significantly lower number of patients with hypoalbuminemia (OR = 0.3, CI 95% [0.2; 0.7], p = 0.006), low vitamin B9 (OR = 0.5, CI 95% [0.2; 1], p = 0.044), and low ferritin (OR = 0.5, CI 95% [0.3; 0.8], p = 0.005) were observed. There was no significant difference in the percentage of excess BMI loss at 1, 2, 3, 4, and 5 years. Compared to OAGB-200 in patients with BMI ≤ 50 kg/m

Sections du résumé

BACKGROUND
It has been suggested that shortening the length of the biliopancreatic limb (BPL) to 150 cm in one anastomosis gastric bypass (OAGB) would reduce nutritional complication rates without impairing weight loss outcomes. The aim of this study is to compare patients who underwent OAGB with a 200-cm BPL (OAGB-200) to patients with OAGB with a 150-cm BPL (OAGB-150) in terms of weight loss and late morbidity.
METHODS
This is a monocentric retrospective matched cohort study including patients with a body mass index between 35 and 50 kg/m
RESULTS
In total, 784 patients who underwent OAGB were included (OAGB-150 n = 392 and OAGB-200 (n = 392). There was no significant difference in terms of early morbidity. Regarding late morbidity in patients with an OAGB-150, significantly lower rates for marginal ulcer (OR = 0.4, CI 95% [0.2; 0.8], p = 0.006), incisional hernia (OR = 0.5, CI 95% [0.3; 1], p = 0.041), and bowel obstruction (OR = 0.3, CI 95% [0.1; 0.9], p = 0.039) were reported. Likewise, regarding late nutritional deficiencies, post-OAGB-150, a significantly lower number of patients with hypoalbuminemia (OR = 0.3, CI 95% [0.2; 0.7], p = 0.006), low vitamin B9 (OR = 0.5, CI 95% [0.2; 1], p = 0.044), and low ferritin (OR = 0.5, CI 95% [0.3; 0.8], p = 0.005) were observed. There was no significant difference in the percentage of excess BMI loss at 1, 2, 3, 4, and 5 years.
CONCLUSION
Compared to OAGB-200 in patients with BMI ≤ 50 kg/m

Identifiants

DOI: 10.1007/s11695-022-06203-9 PMID: 35804236
pubmed: 35804236
doi: 10.1007/s11695-022-06203-9
pii: 10.1007/s11695-022-06203-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2839-2845

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Angrisani L, Santonicola A, Iovino P, et al. similarities and disparities among the 5 IFSO Chapters. Obes Surg. 2018;2021:1–12. https://doi.org/10.1007/s11695-020-05207-7 .
doi: 10.1007/s11695-020-05207-7
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80. https://doi.org/10.1381/096089201321336584 .
doi: 10.1381/096089201321336584 pubmed: 11433900
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8. https://doi.org/10.1007/s11695-014-1552-z .
doi: 10.1007/s11695-014-1552-z pubmed: 25585612
Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet Lond Engl. 2019;393:1299–309. https://doi.org/10.1016/S0140-6736(19)30475-1 .
doi: 10.1016/S0140-6736(19)30475-1
Mahawar KK. Yet Another mortality with a biliopancreatic limb of > 200 cm with one anastomosis gastric bypass. Obes Surg. 2018;28:3634–5. https://doi.org/10.1007/s11695-018-3462-y .
doi: 10.1007/s11695-018-3462-y pubmed: 30105662
Mahawar KK, Parmar C, Carr WRJ, et al. Impact of biliopancreatic limb length on severe protein-calorie malnutrition requiring revisional surgery after one anastomosis (mini) gastric bypass. J Minimal Access Surg. 2018;14:37–43. https://doi.org/10.4103/jmas.JMAS_198_16 .
doi: 10.4103/jmas.JMAS_198_16
Poghosyan T, Caille C, Moszkowicz D, et al. Roux-en-Y gastric bypass for the treatment of severe complications after omega-loop gastric bypass. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2017;13:988–94. https://doi.org/10.1016/j.soard.2016.12.003 .
doi: 10.1016/j.soard.2016.12.003
Ahuja A, Tantia O, Goyal G, et al. MGB-OAGB: effect of biliopancreatic limb length on nutritional deficiency, weight loss, and comorbidity resolution. Obes Surg. 2018;28:3439–45. https://doi.org/10.1007/s11695-018-3405-7 .
doi: 10.1007/s11695-018-3405-7 pubmed: 30032419
Tasdighi E, Barzin M, Mahawar KK, et al. Effect of biliopancreatic limb length on weight loss, postoperative complications, and remission of comorbidities in one anastomosis gastric bypass: a systematic review and meta-analysis. Obes Surg. 2022;32:892–903. https://doi.org/10.1007/s11695-021-05848-2 .
doi: 10.1007/s11695-021-05848-2 pubmed: 35091899
Chevallier J-M, Chakhtoura G, Zinzindohoué F. Laparoscopic mini-gastric bypass. J Chir (Paris). 2009;146:60–4. https://doi.org/10.1016/j.jchir.2009.04.003 .
doi: 10.1016/j.jchir.2009.04.003
Cavin J-B, Voitellier E, Cluzeaud F, et al. Malabsorption and intestinal adaptation after one anastomosis gastric bypass compared with Roux-en-Y gastric bypass in rats. Am J Physiol Gastrointest Liver Physiol. 2016;311:G492-500. https://doi.org/10.1152/ajpgi.00197.2016 .
doi: 10.1152/ajpgi.00197.2016 pubmed: 27418681
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26:926–32. https://doi.org/10.1007/s11695-015-1869-2 .
doi: 10.1007/s11695-015-1869-2 pubmed: 26337694
Bétry C, Disse E, Chambrier C, et al. Need for intensive nutrition care after bariatric surgery. JPEN J Parenter Enteral Nutr. 2017;41:258–62. https://doi.org/10.1177/0148607116637935 .
doi: 10.1177/0148607116637935 pubmed: 26962058
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2015;11:321–6. https://doi.org/10.1016/j.soard.2014.09.004 .
doi: 10.1016/j.soard.2014.09.004
Liagre A, Debs T, Kassir R, et al. One anastomosis gastric bypass with a biliopancreatic limb of 150 cm: weight loss, nutritional outcomes, endoscopic results, and quality of life at 8-year follow-up. Obes Surg. 2020;30:4206–17. https://doi.org/10.1007/s11695-020-04775-y .
doi: 10.1007/s11695-020-04775-y pubmed: 32562132
Omar I, Sam MA, Pegler ME, et al. Effect of one anastomosis gastric bypass on haematinics, vitamin D and parathyroid hormone levels: a comparison between 150 and 200 cm bilio-pancreatic limbs. Obes Surg. 2021;31:2954–61. https://doi.org/10.1007/s11695-021-05281-5 .
doi: 10.1007/s11695-021-05281-5 pubmed: 33594592
Poghosyan T, Alameh A, Bruzzi M, et al. Conversion of sleeve gastrectomy to one anastomosis gastric bypass for weight loss failure. Obes Surg. 2019;29:2436–41. https://doi.org/10.1007/s11695-019-03864-x .
doi: 10.1007/s11695-019-03864-x pubmed: 30945152
Slagter N, de Heide LJM, Jutte EH, et al. Outcomes of the one anastomosis gastric bypass with various biliopancreatic limb lengths: a retrospective single-center cohort study. Obes Surg. 2021;31:4236–42. https://doi.org/10.1007/s11695-021-05555-y .
doi: 10.1007/s11695-021-05555-y pubmed: 34283379 pmcid: 8458216
Abdallah E, Emile SH, Zakaria M, et al. One-anastomosis gastric bypass (OAGB) with fixed bypass of the proximal two meters versus tailored bypass of the proximal one-third of small bowel: short-term outcomes. Surg Endosc. 2022;36:328–35. https://doi.org/10.1007/s00464-020-08284-y .
doi: 10.1007/s00464-020-08284-y pubmed: 33479836
Komaei I, Sarra F, Lazzara C, et al. One anastomosis gastric bypass-mini gastric bypass with tailored biliopancreatic limb length formula relative to small bowel length: preliminary results. Obes Surg. 2019;29:3062–70. https://doi.org/10.1007/s11695-019-04019-8 .
doi: 10.1007/s11695-019-04019-8 pubmed: 31209832

Auteurs

Thibaud Bertrand (T)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique Et Bariatrique, Hôpital Européen Georges Pompidou, Paris, France.

Claire Rives-Lange (C)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.

Anne-Sophie Jannot (AS)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'informatique Médicale, Biostatistiques Et Santé Publique, Hôpital Européen Georges Pompidou, Paris, France.
CRC: Inserm, Centre de Recherche Des Cordeliers, Sorbonne Université, Université de Paris Cité, F-75006, Paris, France.
INRIA: HeKA, Inria Paris, F-75015, Paris, France.

Clement Baratte (C)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique Et Bariatrique, Hôpital Européen Georges Pompidou, Paris, France.

Flore de Castelbajac (F)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.

Estelle Lu (E)

Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'informatique Médicale, Biostatistiques Et Santé Publique, Hôpital Européen Georges Pompidou, Paris, France.

Sylvia Krivan (S)

2Nd Department of General Surgery, Upper Digestive Tract Surgery Center, IASO Group (General Clinic), Athens, Greece.

Maud Le Gall (M)

Université de Paris Cité, F-75015, Paris, France.
Inserm UMRS 1149, Paris, France.

Claire Carette (C)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.

Sebastien Czernichow (S)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.
INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Paris, France.

Jean-Marc Chevallier (JM)

Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique Et Bariatrique, Hôpital Européen Georges Pompidou, Paris, France.

Tigran Poghosyan (T)

Université de Paris Cité, F-75015, Paris, France. tigran.poghosyan@aphp.fr.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique Et Bariatrique, Hôpital Européen Georges Pompidou, Paris, France. tigran.poghosyan@aphp.fr.
Inserm UMRS 1149, Paris, France. tigran.poghosyan@aphp.fr.
ORCID: 0000-0002-7103-1088

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie digestive › Gastroentérostomie › Dérivation gastrique › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Troubles nutritionnels › Malnutrition › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Obésité morbide › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Score de propension › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › 150-cm Versus 200-cm Biliopancreatic Limb...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Mensurations corporelles › Poids › Modifications du poids corporel › Perte de poids › 150-cm Versus 200-cm Biliopancreatic Limb...